Director/PDMR Shareholding (0662I)
June 08 2011 - 4:21AM
UK Regulatory
TIDMMEDG TIDMMEDU
RNS Number : 0662I
Medgenics Inc
08 June 2011
Medgenics, Inc.
(the "Company")
Issue of Equity and Director/PDMR Shareholding
8 June 2011
Medgenics, Inc. (NYSE Amex: MDGN and MDGN.W and London Stock
Exchange - AIM: MEDG and MEDU), the company that has developed a
novel technology for the manufacture and delivery of therapeutic
proteins continuously in patients using their own tissue, announces
that on May 12, 2011 the Company issued a total of 22,945 new
common shares of par value U.S. $0.0001 each in the Company
("Common Shares") and on May 27, 2011 the Company issued 18,269 new
Common Shares as a result of exercises of options over and above
the remaining capacity available under the Company's existing Block
Admission- which exhausted remaining capacity in the six months to
June 4, 2011 as announced on June 8, 2011.
This issue of Common Shares includes the issue of 18,269 Common
Shares to Gary Brukardt, a director of the Company, following the
exercise of 60,507 warrants (with an exercise price of U.S. $2.49
per Common Share) to subscribe for new Common Shares using the
cashless exercise mechanism on 27 May 2011. As a result of this
exercise of warrants, Gary Brukardt is now interested in a total of
49,880 Common Shares. This holding represents approximately 0.5 per
cent of the Company's issued share capital.
In addition to his interest in the Company's common share
capital, Mr. Brukardt is interested in the following options and
warrants to subscribe for Common Shares:
% of % of
Issued Issued
Common Share Expiry Exercise Total Share
Shares Capital Instrument Number Date Price Interests Capital
----------- ------ ------- ---------- -------- ---------- -------- --------- -------
Gary
Brukardt
(Director) 49,880
----------- ------ ------- ---------- -------- ---------- -------- --------- -------
Options 45,701 18/09/2011 $2.49
----------- ------ ------- ---------- -------- ---------- -------- --------- -------
Options 26,705 14/11/2012 $7.35
----------- ------ ------- ---------- -------- ---------- -------- --------- -------
Options 28,571 14/09/2020 $8.19
----------- ------ ------- ---------- -------- ---------- -------- --------- -------
Options 12,857 12/01/2021 $6.55
----------- ------ ------- ---------- -------- ---------- -------- --------- -------
Total 49,880 0.5% 113,834 163,714 1.7%
----------- ------ ------- ---------- -------- ---------- -------- --------- -------
Application will been made for the new Common Shares, which rank
pari passu with the Company's existing issued share capital, to be
admitted to trading on AIM and it is expected that the admission
will occur on June 15, 2011.
Following the issue and allotment of the new Common Shares
referred to herein and the 170,501 issued under the Company's
existing Block Admission, the Company will have a total of
9,631,198 Common Shares in issue and the percentage of shares not
in public hands will be 32.9%.
The Company has also made an application for a block admission,
in accordance with the AIM Rules, for 1,926,239 Common Shares (in
relation to the Company's outstanding warrants and options under
its share incentive plans) which represents approximately 20% of
the Company's currently issued share capital. It is expected that
this block admission will be effective from June 15, 2011.
For further information, contact:
Medgenics, Inc. Phone: +972 4 902 8900
Dr. Andrew L. Pearlman
Religare Capital Markets (Nominated Phone: +44 20 7444 0800
Adviser)
James Pinner
Derek Crowhurst
SVS Securities plc (Joint Broker) Phone: +44 20 7638 5600
Ian Callaway
Nomura Code Securities PLC (Joint Phone: +44 20 7776 1219
Broker)
Jon Senior
De Facto Financial Phone: +44 207 556 1064
Mike Wort
Anna Dunphy
Lippert/Heilshorn & Associates, Inc. Phone: +1 212-838-3777
(Investment Relations - US)
Anne Marie Fields
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEAPKPEFPFEEF
Medgenics(Regs) (LSE:MEDG)
Historical Stock Chart
From Jul 2024 to Aug 2024
Medgenics(Regs) (LSE:MEDG)
Historical Stock Chart
From Aug 2023 to Aug 2024